ELI LILLY AND COMPANY Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax
ELI LILLY AND COMPANY (LLY) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax of $186.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-20.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax · last filed 2018-02-20
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for the quarter ending 2017-12-31 was $210.60M, a 0.14% increase year-over-year.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for the quarter ending 2017-09-30 was -$9.40M.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for the quarter ending 2017-06-30 was -$6.10M.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for the quarter ending 2017-03-31 was -$8.50M.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for fiscal 2017 was $186.60M, a 21.72% increase from fiscal 2016.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for fiscal 2016 was $153.30M.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for fiscal 2015 was -$183.00M, a 144.13% decline from fiscal 2014.
- ELI LILLY AND COMPANY other comprehensive (income) loss, defined benefit plan, before reclassification adjustment, tax for fiscal 2014 was $414.70M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax 6 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $210.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $201.20M derived: sum of 2 quarters · filed 2018-02-20 | $195.10M derived: sum of 3 quarters · filed 2018-02-20 | $186.60M 10-K · filed 2018-02-20 | ||
| 2017-09-30 | -$9.40M 10-Q · filed 2017-10-27 | -$15.50M derived: sum of 2 quarters · filed 2017-10-27 | -$24.00M 10-Q · filed 2017-10-27 | $186.30M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2017-06-30 | -$6.10M 10-Q · filed 2017-07-28 | -$14.60M 10-Q · filed 2017-07-28 | $195.70M derived: sum of 3 quarters · filed 2018-02-20 | $186.20M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2017-03-31 | -$8.50M 10-Q · filed 2017-05-01 | $201.80M derived: sum of 2 quarters · filed 2018-02-20 | $192.30M derived: sum of 3 quarters · filed 2018-02-20 | $170.50M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2016-12-31 | $210.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $200.80M derived: sum of 2 quarters · filed 2018-02-20 | $179.00M derived: sum of 3 quarters · filed 2018-02-20 | $153.30M 10-K · filed 2018-02-20 | ||
| 2016-09-30 | -$9.50M 10-Q · filed 2017-10-27 | -$31.30M derived: sum of 2 quarters · filed 2017-10-27 | -$57.00M 10-Q · filed 2017-10-27 | -$333.90M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2016-06-30 | -$21.80M 10-Q · filed 2017-07-28 | -$47.50M 10-Q · filed 2017-07-28 | -$324.40M derived: sum of 3 quarters · filed 2018-02-20 | -$293.30M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2016-03-31 | -$25.70M 10-Q · filed 2017-05-01 | -$302.60M derived: sum of 2 quarters · filed 2018-02-20 | -$271.50M derived: sum of 3 quarters · filed 2018-02-20 | -$291.80M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2015-12-31 | -$276.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | -$245.80M derived: sum of 2 quarters · filed 2018-02-20 | -$266.10M derived: sum of 3 quarters · filed 2018-02-20 | -$183.00M 10-K · filed 2018-02-20 | ||
| 2015-09-30 | $31.10M 10-Q · filed 2016-10-28 | $10.80M derived: sum of 2 quarters · filed 2016-10-28 | $93.90M 10-Q · filed 2016-10-28 | $312.20M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-06-30 | -$20.30M 10-Q · filed 2016-07-28 | $20.30M 10-Q · filed 2015-07-30 | -$62.80M 10-Q · filed 2016-07-28 | $62.80M 10-Q · filed 2015-07-30 | $281.10M derived: sum of 3 quarters · filed 2017-02-21 | $311.90M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | -$42.50M 10-Q · filed 2016-04-29 | $42.50M 10-Q · filed 2015-04-30 | $301.40M derived: sum of 2 quarters · filed 2017-02-21 | $332.20M derived: sum of 3 quarters · filed 2017-02-21 | $348.70M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2014-12-31 | $343.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $374.70M derived: sum of 2 quarters · filed 2017-02-21 | $391.20M derived: sum of 3 quarters · filed 2017-02-21 | $414.70M 10-K · filed 2017-02-21 | ||
| 2014-09-30 | $30.80M 10-Q · filed 2015-10-30 | $47.30M derived: sum of 2 quarters · filed 2015-10-30 | $70.80M 10-Q · filed 2015-10-30 | -$952.50M derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2014-06-30 | $16.50M 10-Q · filed 2015-07-30 | $40.00M 10-Q · filed 2015-07-30 | -$983.30M derived: sum of 3 quarters · filed 2016-02-19 | -$935.20M derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2014-03-31 | $23.50M 10-Q · filed 2015-04-30 | -$999.80M derived: sum of 2 quarters · filed 2016-02-19 | -$951.70M derived: sum of 3 quarters · filed 2016-02-19 | -$909.60M derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2013-12-31 | -$1.02B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$975.20M derived: sum of 2 quarters · filed 2016-02-19 | -$933.10M derived: sum of 3 quarters · filed 2016-02-19 | -$886.10M 10-K · filed 2016-02-19 | ||
| 2013-09-30 | $48.10M 10-Q · filed 2014-10-29 | $90.20M derived: sum of 2 quarters · filed 2014-10-29 | $137.20M 10-Q · filed 2014-10-29 | |||
| 2013-06-30 | $42.10M 10-Q · filed 2014-07-28 | $89.10M 10-Q · filed 2014-07-28 | ||||
| 2013-03-31 | $47.20M 10-Q · filed 2014-04-28 | |||||
| 2012-12-31 | -$34.40M 10-K · filed 2015-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |